When will I receive my medication
Our analysis revealed a substantial increase in GLP-1 RA utilization, with nearly 1 in 5 US adults with diabetes using these medications in 2021 and 2022, a marked increase compared with estimates prior to 2020
Furthermore, their combined mechanism provides a unique research advantage
Getting Started with Medical Weight Loss Your first step on a medical weight loss journey includes a consultation at our luxury weight loss medical clinic in Alpharetta, GA
PLoS ONE 20 , e0321140 (2025)
Retatrutide has a long half-life estimated at approximately six days based on phase 2 pharmacokinetic data (Jastreboff et al., NEJM 2023) meaning that drug levels rise gradually and remain relatively stable between weekly doses once a steady state is achieved (typically after approximately four to five half-lives, or around four to five weeks of weekly dosing)